Related Experiment Video
Updated: Aug 12, 2026
08:38
Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
[Immunosuppressive agents in pediatric renal transplantation]
K Ismaili1, D Abramowicz, B Adams
1Départment de Néphrologie, Hémodialyse et Transplantation renale, H.U.D.E.R.F., Bruxelles.
Revue Medicale De Bruxelles
|February 4, 2006
Summary
Recent advances in immunosuppressive therapy have significantly improved transplant survival. Future developments aim for better drug combinations and tolerance induction to enhance long-term graft success and minimize side effects.
Area of Science:
- Immunology
- Pharmacology
- Transplantation Medicine
Context:
- Immunosuppressive therapy is crucial for transplant success.
- Therapeutic strategies are continuously evolving.
- Balancing efficacy and adverse effects remains a key challenge.
Purpose:
- To review recent advancements in immunosuppressive therapy.
- To highlight the ongoing evolution of immunosuppression protocols.
- To discuss future directions in optimizing transplant outcomes.
Summary:
- Significant improvements in patient and graft survival have been achieved through advances in immunosuppressive therapy.
- Current research focuses on identifying optimal immunosuppressive combinations.
- Minimizing adverse effects while maximizing long-term graft survival is the primary objective.
Impact:
- Enhanced patient and graft survival rates in organ transplantation.
- Potential for further improvements with novel medications and tolerance induction.
- Improved quality of life for transplant recipients.
Related Concept Videos
01:28Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...